PLUS1
109.41
-1.44 (-1.3%)
-1.44 (-1.3%)
Upgrade to Real-Time
Regular Market
| Volume | 5,018,496 |
|
|||||
| News | - | ||||||
| Day High | 111.37 | Low High |
|||||
| Day Low | 109.31 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.44 | -1.3% | 109.41 | 14:15:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 110.78 | 109.31 | 111.37 | 110.85 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 51,676 | 5,018,496 | $ 110.30 | $ 553,558,376 | - | 71.97 - 111.37 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:15:07 | 1 | $ 109.43 | USD |
Period:
Draw Mode:
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 277.40B | 2.54B | 2.53B | $ 50.16B | $ 12.97B | 5.14 | 18.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.64 | 2.65% | 12/14/22 | -2.92M | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 109.00 | 111.37 | 108.42 | 109.98 | 7,395,649 | 0.41 | 0.38% |
| 1 Month | 100.53 | 111.37 | 97.33 | 106.11 | 9,032,547 | 8.88 | 8.83% |
| 3 Months | 86.61 | 111.37 | 84.52 | 97.34 | 9,275,567 | 22.80 | 26.32% |
| 6 Months | 89.15 | 111.37 | 83.05 | 93.10 | 9,392,072 | 20.26 | 22.73% |
| 1 Year | 73.53 | 111.37 | 71.97 | 86.91 | 10,759,313 | 35.88 | 48.8% |
| 3 Years | 89.14 | 111.37 | 65.25 | 81.59 | 11,108,609 | 20.27 | 22.74% |
| 5 Years | 55.57 | 111.37 | 52.83 | 77.87 | 10,711,507 | 53.84 | 96.89% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States. |